Sage Therapeutics, Inc. SAGE
8.68 0.00 0.00%
At close · Jul 31
52-week range unavailable
- YTD
- +59.85%
- 1 year
- -19.63%
- Open
- 8.68
- Prev close
- 8.68
- Mkt cap
- 544.94M
- Vol
- 17.39M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.68
- High
- 8.68
- Forward P/E
- -1.30
- Beta
- 0.92
- Short ratio
- 7.21
- Inst. own
- 86.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 6.09
- 200-d avg
- 10.24
- 1y target
- 9.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for SAGE has not been loaded yet. Try again in a moment.
Altman Z-Score
-5.33 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.8×
P/S 8.0×
P/B 0.7×
P/FCF -1.2×
EV/EBITDA -0.6×
EV/Sales 6.3×
FCF Yield -81.0%
Gross Margin 77.1%
Operating Margin -1048.3%
Net Margin -971.5%
ROE -86.1%
ROIC -90.7%
ROA -73.2%
Revenue -52.3%
Operating Income 25.4%
EPS (diluted) 27.2%
Free Cash Flow 50.6%
Current Ratio 7.4×
Quick Ratio 7.4×
Debt / Equity 0.0×
Net Debt / EBITDA 0.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2024-12-31